Understanding rates of attrition and barriers to surgical resection in patients undergoing neoadjuvant therapy for localized pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast Recurrence Score® result provides more accurate estimates about that patient’s ...